CervoMed Inc.CRVONASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P46
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -1.71% |
| Q3 2025 | 0.76% |
| Q2 2025 | -67.29% |
| Q1 2025 | 51.63% |
| Q4 2024 | -65.84% |
| Q3 2024 | -120.50% |
| Q2 2024 | -54.65% |
| Q1 2024 | 43.92% |
| Q4 2023 | -193.92% |
| Q3 2023 | 237.77% |
| Q2 2023 | -32.38% |
| Q1 2023 | 57.33% |
| Q4 2022 | -150.66% |
| Q3 2022 | 271.11% |
| Q2 2022 | 15.28% |
| Q1 2022 | -56.33% |
| Q4 2021 | -1.78% |
| Q3 2021 | 10.67% |
| Q2 2021 | 35.72% |
| Q1 2021 | -52.49% |
| Q4 2020 | 3.29% |
| Q3 2020 | -11.65% |
| Q2 2020 | 10.29% |
| Q1 2020 | -43.74% |
| Q4 2019 | -13.25% |
| Q3 2019 | 17.52% |
| Q2 2019 | 1.78% |
| Q1 2019 | 12.22% |
| Q4 2018 | -57.98% |
| Q3 2018 | 24.56% |
| Q2 2018 | 22.78% |
| Q1 2018 | -44.12% |
| Q4 2017 | 41.30% |
| Q3 2017 | -41.59% |
| Q2 2017 | 19.61% |
| Q1 2017 | -141.54% |
| Q4 2016 | 24.16% |
| Q3 2016 | 34.78% |
| Q2 2016 | 38.25% |
| Q1 2016 | -79.85% |